报告非劣质和等效随机试验:扩展CONSORT 2010声明的内容
Gilda Piaggio1, Diana R Elbourne, Stuart J Pocock
1Statistika Consultoria, São Paulo, Brazil. gilda.piaggio@gmail.com
JAMA
|December 27, 2012
概括
这项研究更新了CONSORT检查清单,以改善非劣等性和等效性试验的报告. 改进的指南帮助读者评估随机对照试验结果的可靠性.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 基于证据的医学基于证据的医学.
背景情况:
- CONSORT声明 (报告试验的综合标准) 提供了报告随机对照试验 (RCT) 的指导方针.
- 现有的CONSORT指南主要关注优越性试验,并于2010年进行了最后一次更新.
- 关于非劣质性和等效性试验的先前建议是在2006年提出的.
研究的目的:
- 提出CONSORT检查清单的更新扩展,专门用于报告非劣等性和等效性试验.
- 提高这些特定试验设计报告的清晰度和完整性.
- 帮助读者评估非劣等性和等效性试验的可靠性和结论.
主要方法:
- 更新的检查清单是基于2010年CONSORT声明和2008年CONSORT声明进行抽象报告.
- 该扩展涉及特定于非劣质性和等效性试验设计的项目.
- 对于修改后的检查列表项目,提供了说明性示例和解释.
主要成果:
- 这篇文章介绍了一份改进的CONSORT检查清单,适用于非劣等性和等效性试验.
- 这份更新的检查清单包含了超出标准优越性试验报告范围的具体考虑.
- 其目标是标准化和提高已公布的试验数据的质量.
结论:
- 更新的CONSORT检查清单扩展旨在改善非劣质性和等效性试验的报告.
- 更好的报告将提高试验结果的透明度和可解释性.
- 该资源将帮助研究人员和读者评估试验结果的有效性.
相关概念视频
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...